Principal Investigator: ODUWWOLE, ADEFISAYO
Coordinator: CROSS, JO ANN RN
Start date 02/2016 Scheduled closeout 07/2016
Anticipated enrollment 10
Summary
A Randomized, Open-Label, Daily Dose, Two-sequence, Two-way Crossover Pharmacodynamic and Pharmacokinetic Study of BiDil XR Capsules and Commercial BiDil Tablets in Self-identified Black Patients, who are Slow Acetylators, with Heart Failure (BiDiL XR)